摘要
支气管哮喘(简称哮喘)是多基因参与的、以慢性气道炎症、气道高反应性及气道重塑为特征的症候群。缓解哮喘急性发作,控制哮喘发生,长期控制以嗜酸粒细胞、肥大细胞、单核细胞、淋巴细胞浸润为特征的气道炎症,抑制气道重塑,是目前治疗的新策略。本文对常用药物的使用,患者教育,以及呼吸道感染与哮喘的关系进行了综述,对临床实践具有一定的指导意义。
Asthma is a muhi-gene involved disease characterized by chronic airway inflammation, airway hyperreactivity and airway remodeling. The new stragtegy for treatment of asthma is to relief the occurrence of acute asthma symptom, long-term control the airway inflammation infiltrated by eosinophils, mast cells, monocytes and lymphocytes, and to inhibit airway remodeling. This article summarized the common drugs,health education,the ralationship between respiratory infections and asthma,which should be help- ful in clinical practice.
出处
《医学综述》
2008年第23期3615-3618,共4页
Medical Recapitulate
